CD19 and acute lymphoblastic leukemia: Specifically for lymphoblastic leukemia, the effect of PTL has been evaluated by Diamanti, who demonstrated that this compound can induce apoptosis in CD34+CD19− or CD34+CD7− ALL cells, preventing the engraftment capacity in NSG models [2].